michael kors handbags ny 2016

When in actual sales may be less than 10 billion, that is to say, when the R \u0026 D investment is very limited. Seeking private financing or M \u0026 A has become an important way of addition to bank lending. A noteworthy detail is that public reports show that at the end of 2012, Jiangxi Jimin credible Group acquired a 51% interest in Zhejiang Kanglaite given 15 times earnings, the equity valuation of about 750 million yuan, but this case has been the acquisition of equity Zhejiang Kanglaite company has not been confirmed. Reporters noted that the Group Jiangxi Jimin credible official website revealed that Zhejiang Kanglaite company for the group 'strategic partner' and its strategic products are displayed on display on its website. In three or four years ago, before the share acquisition, Zhejiang Kanglaite has sought to be acquired, and there had been in talks to buy step group, but I do not know why because eventually ran aground. Analysis of the industry, is the value of the acquirer ability KLT anticancer injection in the domestic market continued profitability. Public information shows that in 2008, Zhejiang Kanglaite company said sales have exceeded 40 million. In July 2005, KLT completed clinical trials in Russia and started selling, while in the United States and also completed a clinical. In fact, R \u0026 D funding gap has been accompanied by the development of this private pharmaceutical companies, as the only option or sell the shares of Zhejiang Kanglaite. Currently, anti-cancer KLT injection in domestic sales exceeded 10 billion yuan, but the need for greater investment in future Phase III clinical trials in the United States. In addition to the United States, the company will carry out simultaneously in China, Eastern Europe, is expected to total included 750 patients, it is expected to invest the funds will not be less than $ 50 million. Chinese medicine has long been engaged in the study of Hubei Medical University doctoral Wu and Jane does not deny that he accepted the Yangtze River Chinese Commercial News reporter Zhuan Fangzai July 1 when the view that drug development cycle long, costly, and risks coexist, not general business can bear . He explained that a new drug from the preliminary investigation, research and development to final approval by the Government, the general period of 10 years at a cost of one billion yuan normal. The research Waterhouse researcher Li Hu told Changjiang Daily reporter, mostly proprietary compound, and complex components. Basic research for the domestic Chinese medicine is not effective substance